Sign In   |   Register
Themed Short Track - July/August 2018
Share |

Introducing Themed Short Tracks

In SHORT TRACKS we collect 2-4 recent lectures from EAS congresses or courses, putting them together to provide up-to-date perspectives on a given current topic.

This month’s SHORT TRACK topic is Current Issues in Dietary Management of Dyslipidemia. Dietary recommendations still trigger a lot of debate both among professionals and the general public. Thus, we believe you will be attracted to view our selection of the three illustrative presentations we have gathered and described below.

To the SHORT TRACK Current Issues in Dietary Management of Dyslipidemia>> 

These presentations are open for EAS members only. Register as an EAS Individual member, and the whole ACADEMY is open for you.

How to register as an EAS member >>

Nordic and Mediterranean diet patterns from the CVD point of view

In the first presentation Dr. Ursula Schwab discusses the differences and similarities of the two distinctive dietary patterns: the frequently studied Mediterranean and, also, the Nordic. Though you can identify similarities in terms of contents of these diets there are important features to be noticed and taken into account when considering their role in lipid metabolism and CVD risk determination.

To the presentation >>

Diet and cardiometabolic health

In the second presentation Dr. Qi Sun summarizes the current evidence and comes back to the hot topics about the impact of replacement of different dietary components with the others, what the role of food processing and cooking techniques is and their impact on potential cardiovascular impact of nutrients and many more. A comprehensive talk you should not miss to learn what is currently moving the field.

To the presentation >>

Updates on the guidelines. Which role for nutraceuticals?

The third of this edition of EAS Academy Short tracks is a talk by Dr. Emilio Ros, the well-known primary investigator of the PREDIMED study. This time he reviews another new area connected with dietary treatment of dyslipidemia and cardiovascular risk, the bridge between lifestyle and pharmacological interventions – nutraceuticals. Much noise and not entirely correct information have hampered navigation of both professionals and patients in this field. Thus, a clear summary of evidence and state-of-the art update as excellently provided by dr. Ros is very much needed.

To the presentation >>

Membership Software Powered by YourMembership  ::  Legal